Ticker > Company >

Krishna Inst.Medi share price

Krishna Institute of Medical Sciences Ltd

NSE: KIMS BSE: 543308 SECTOR: Hospital & Healthcare Services  121k   203   50

679.75
+18.40 (2.78%)
BSE: 13 Jun 04:01 PM

Price Summary

Today's High

₹ 685

Today's Low

₹ 640.2

52 Week High

₹ 707.5

52 Week Low

₹ 401.6

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

27199.44 Cr.

Enterprise Value

27505.25 Cr.

No. of Shares

40.01 Cr.

P/E

89.8

P/B

12.55

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  54.18

CASH

20.48 Cr.

DEBT

326.29 Cr.

Promoter Holding

38.82 %

EPS (TTM)

₹  7.57

Sales Growth

7.95%

ROE

13.46 %

ROCE

17.02%

Profit Growth

-6.79 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Krishna Institute of Medical Sciences Ltd

KIMS Hospitals KIMS Cuddles

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year7.95%
3 Year9.43%
5 Year11.57%

Profit Growth

1 Year-6.79%
3 Year7.65%
5 Year49.19%

ROE%

1 Year13.46%
3 Year18.2%
5 Year20.15%

ROCE %

1 Year17.02%
3 Year23.61%
5 Year24.62%

Debt/Equity

0.1748

Price to Cash Flow

103.66

Interest Cover Ratio

43.5362

CFO/PAT (5 Yr. Avg.)

1.18011491218939

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 38.82 12.03
Dec 2024 38.82 12.13
Sep 2024 38.82 15.35
Jun 2024 38.82 15.78
Mar 2024 38.82 16.10
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROCE of 23.6110333333333% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 43.5362.
  • The Company has been maintaining an effective average operating margins of 31.1647% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -63.7137 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.18011491218939.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.71829044730724.

 Limitations

  • The company has shown a poor profit growth of 7.65008135316969% for the Past 3 years.
  • The company has shown a poor revenue growth of 9.42522699255053% for the Past 3 years.
  • Company has contingent liabilities of 581.991 Cr.
  • The company is trading at a high PE of 89.8.
  • The company is trading at a high EV/EBITDA of 58.9137.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 304.8 327.4 363.3 347.5 345.9
Total Expenditure 218.5 233.6 252.2 244.6 237.1
Operating Profit 86.3 93.8 111.1 102.9 108.8
Other Income 3.9 5.3 6.6 20.6 24.2
Interest 2.3 3.8 4.6 6.7 8.2
Depreciation 20.4 13.7 14 14.9 15.1
Exceptional Items 0 0 0 0 10.8
Profit Before Tax 67.5 81.6 99.1 101.9 120.5
Tax 19.3 20.9 26.9 25.4 27
Profit After Tax 48.2 60.7 72.2 76.5 93.5
Adjusted EPS (Rs) 1.21 1.52 1.8 1.91 2.34

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 789.97 932.69 1143.38 1132.02 1222.05
Total Expenditure 584.14 625.11 745.5 768.88 856.5
Operating Profit 205.84 307.58 397.88 363.14 365.55
Other Income 7.09 9.62 26.96 24.28 18.21
Interest 23.76 18.33 8.91 4.8 7.48
Depreciation 42.66 44.6 44.92 45.3 58.11
Exceptional Items 0 0 0 0 0
Profit Before Tax 146.51 254.26 371 337.33 318.17
Tax 25.4 65.61 92.64 84.84 82.83
Net Profit 121.11 188.65 278.37 252.49 235.34
Adjusted EPS (Rs.) 3.25 4.86 6.96 6.31 5.88

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 74.49 77.59 80.03 80.03 80.03
Total Reserves 549.64 829.73 1297.52 1550.83 1786.42
Borrowings 147.12 67.78 4.17 0 257.17
Other N/C liabilities 48.24 48.53 52.81 61.53 63.62
Current liabilities 137.95 190.09 134.25 119.68 209.26
Total Liabilities 957.44 1213.73 1568.78 1812.07 2396.51
Assets
Net Block 559.21 582.39 591.97 612.28 673.92
Capital WIP 2.23 7.6 13.19 15.97 291.98
Intangible WIP 0 0 0 0 0
Investments 177.96 213.22 542.01 784.87 1000.65
Loans & Advances 48.66 38.94 88.18 158.74 126.81
Other N/C Assets 0.14 4.35 2.16 3.17 1.98
Current Assets 169.24 367.23 331.28 237.04 301.17
Total Assets 957.44 1213.73 1568.78 1812.07 2396.51
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 146.51 254.26 371 337.33 318.17
Adjustment 62.08 54.74 26.5 25.4 47.6
Changes in Assets & Liabilities -0.99 25.07 -16.85 -17.17 -18.06
Tax Paid -47.01 -42.72 -96.28 -74.52 -85.31
Operating Cash Flow 160.59 291.35 284.37 271.05 262.39
Investing Cash Flow -108.03 -316.6 -375.08 -237.67 -568.65
Financing Cash Flow -24.35 25.37 75.98 -15.14 288.64
Net Cash Flow 28.21 0.12 -14.73 18.24 -17.62

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 38.82 38.82 38.82 38.82 38.82
abhinay bollineni 0.06 0.06 0.06 0.06 0.06
adwik bollineni 0.01 0.01 0.01 0.01 0.01
b krishnaiah 0.22 0.22 0.22 0.22 0.22
bhaskara rao bollineni 26.27 26.27 26.27 26.27 26.27
bluebridge capital privat... - - - 6.05 6.05
bollineni aishwarya 0.18 0.18 0.18 0.18 0.18
bollineni seenaiah naidu... 4.27 4.27 4.27 4.27 4.27
rajyasri bollineni 1.72 1.72 1.72 1.72 1.72
sujatha bollineni 0.04 0.04 0.04 0.04 0.04
sweata raavi 0.01 0.01 0.01 0.01 0.01
bollineni ramanaiah memor... 6.05 6.05 6.05 - -
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 61.18 61.18 61.18 61.18 61.18
amansa holdings private l... 2.02 1.99 1.93 1.93 1.93
axis mutual fund trustee ... 4.81 4.42 4.42 4.96 5.17
hdfc life insurance compa... 1.77 1.89 1.71 1.28 1.19
hdfc small cap fund 4.25 4.20 4.34 4.41 4.49
kotak small cap fund 1.04 1.60 2.86 2.86 3.07
lilac investments limited... - - 1.96 1.96 1.96
llp 0.01 0.03 0.01 0.01 0.01
nippon life india trustee... 1.33 1.33 1.64 1.65 1.67
nomura india investment f... 1.77 1.77 1.77 1.72 1.72
sbi life insurance co. lt... 1.77 1.85 2.87 2.90 3.52
sbi small cap fund 7.20 7.23 7.21 7.10 6.31
tata aia life insurance c... 1.64 1.64 1.46 1.43 1.40
venkata krishna kumar kod... - 1.26 1.26 1.26 1.26
icici prudential elss tax... - - 1.41 - -
emerald investments limit... 1.96 1.96 - - -
icici prudential long ter... 1.68 1.80 - - -
aicpk9496n 1.26 - - - -
hsbc small cap fund 1.31 - - - -
mirae asset aggressive hy... 1.17 - - - -

Annual Reports

Title Action
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2016
Annual Report 2015

Ratings & Research Reports

TYPE AGENCY ACTION
Credit CRISIL
TYPE AGENCY ACTION
Research Way 2 Wealth
Research Edelweiss
Research NuvamaWealth
Research Nuvama Wealth
Research Edelweiss
Research HDFC Securities
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss

Concalls & Presentations

TYPE QUARTER ACTION
Concall Q4FY24
Concall Q4FY22
Concall Q3FY25
Concall Q3FY24
Concall Q3FY23
Concall Q2FY24
Concall Q1FY25
Concall Q1FY24
TYPE QUARTER ACTION
Presentation Q4FY24
Presentation Q4FY22
Presentation Q3FY24
Presentation Q3FY22
Presentation Q2FY24
Presentation Q2FY22
Presentation Q1FY25
Presentation Q1FY24

Company News

Krishna Inst.Medi Stock Price Analysis and Quick Research Report. Is Krishna Inst.Medi an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Krishna Inst.Medi and its performance over the period of time. Krishna Inst.Medi stock price today is Rs 679.95.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Krishna Inst.Medi cash from the operating activity was Rs 262.389 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Krishna Inst.Medi has a Debt to Equity ratio of 0.1748 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Krishna Inst.Medi , the EPS growth was -6.7917 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Krishna Inst.Medi has OPM of 29.912753446247 % which is a good sign for profitability.
     
  • ROE: Krishna Inst.Medi have a average ROE of 13.4584 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Krishna Inst.Medi is Rs 679.95. One can use valuation calculators of ticker to know if Krishna Inst.Medi share price is undervalued or overvalued.
Last Updated on:
Brief about Krishna Inst.Medi
X